Related Experiment Video
Updated: Jan 28, 2026
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.8K
Stromal sarcoma of the prostate.
Millard Henry1, Cameron Britton, Caitlin Coco
1Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
The Canadian Journal of Urology
|February 25, 2019
Summary
Prostatic stromal sarcoma is a rare cancer. This case study presents a unique, slow-growing prostatic stromal sarcoma, differing from typical aggressive presentations, and discusses treatment outcomes.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Primary spindle cell sarcoma of the prostate is exceptionally rare, comprising 0.1% of all prostate cancers.
- The typical clinical course is aggressive, associated with a poor prognosis.
Observation:
- A case of prostatic stromal sarcoma (PSS) is presented, which appeared to be dormant for years post-transurethral resection of the prostate.
- This PSS case exhibited unusually slow growth, contrasting with previously reported aggressive PSS.
- The patient underwent a cystoprostatectomy and ileal conduit surgery.
Findings:
- This report details a rare presentation of a rare prostatic tumor.
- The slow-growing nature of this PSS challenges the conventional understanding of its typical rapid progression.
Implications:
- This case expands the clinical spectrum of prostatic stromal sarcoma.
- Understanding rare presentations is crucial for accurate diagnosis and treatment planning in rare cancers.
